Posters & Publications

A Novel Splicing- Targeted ADC Drives Immune Activation, Synergy with Checkpoint Inhibitors, and Enhanced Therapeutic Potential beyond Cytotoxicity – SITC November 2025

DOWNLOAD POSTER

---

Peak Bio, Inc. Presents Preclinical Data Highlighting Potential of Differentiated Trop2 ADC at the 2023 AACR Annual Meeting

DOWNLOAD POSTER

---

Peak Bio, Inc introduces a novel immunostimulatory ADC payload targeting RNA splicing and demonstrates tumoricidal properties of a proof-of concept Her2 ADC at the 2021 AACR annual meeting

DOWNLOAD POSTER